Cardiac Arrest Outcomes in Children With Preexisting Neurobehavioral Impairment

James R Christensen1,2,3, Beth S Slomine2,4,5, Faye S Silverstein6,7

  • 1Department of Pediatric Rehabilitation Medicine, Kennedy Krieger Institute, Baltimore, MD.

Insights

In children with preexisting neurobehavioral impairment, targeted temperature management trials show one-third survival to 12 months, with varied neurobehavioral outcomes. This highlights challenges in pediatric neuroprotection research.

Area of Science:

  • Pediatric critical care medicine
  • Neuroscience
  • Clinical trials

Background:

  • Children with preexisting neurobehavioral impairment face unique challenges after cardiac arrest.
  • Targeted temperature management (TTM) is a critical intervention for post-cardiac arrest care.
  • Understanding outcomes in this vulnerable population is crucial for improving neuroprotection strategies.

Purpose of the Study:

  • To assess survival and neurobehavioral outcomes at 3 and 12 months in children with preexisting neurobehavioral impairment who underwent TTM.
  • To analyze the feasibility and utility of including this population in neuroprotection trials.

Main Methods:

  • Secondary analysis of data from two parallel randomized clinical trials (Therapeutic Hypothermia after Pediatric Cardiac Arrest In-Hospital and Out-of-Hospital).
  • Inclusion of 84 pediatric participants with precardiac arrest neurobehavioral impairment (Vineland Adaptive Behavior Scales, Second Edition composite score < 70).
  • Assessment of neurobehavioral function using the Vineland Adaptive Behavior Scales, Second Edition at baseline, 3 months, and 12 months post-cardiac arrest.

Main Results:

  • Overall survival to 12 months was 33% (28/84).
  • Neurobehavioral scores (Vineland Adaptive Behavior Scales, Second Edition) declined significantly at 3 months post-cardiac arrest.
  • At 12 months, neurobehavioral outcomes varied, with 43% (12/28) showing unchanged or improved scores, particularly in the in-hospital cardiac arrest group.

Conclusions:

  • Including children with preexisting neurobehavioral impairment in neuroprotection trials is feasible but challenging.
  • One-third of these children survived to 12 months, but their neurobehavioral outcomes demonstrated considerable variability.
  • Findings underscore the need for tailored approaches and further research in this specific pediatric population.
Abstract

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.8K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.1K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.8K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
454
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
283
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.3K